Welcome to LookChem.com Sign In|Join Free
  • or
Pyrimido[4,5-d]pyrimidin-4-amine (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

26979-05-5

Post Buying Request

26979-05-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26979-05-5 Usage

Synthesis Reference(s)

Journal of the American Chemical Society, 82, p. 3138, 1960 DOI: 10.1021/ja01497a039

Check Digit Verification of cas no

The CAS Registry Mumber 26979-05-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,9,7 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 26979-05:
(7*2)+(6*6)+(5*9)+(4*7)+(3*9)+(2*0)+(1*5)=155
155 % 10 = 5
So 26979-05-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H5N5/c7-5-4-1-8-2-10-6(4)11-3-9-5/h1-3H,(H2,7,8,9,10,11)

26979-05-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name pyrimido[4,5-d]pyrimidin-4-amine

1.2 Other means of identification

Product number -
Other names 4-aminopyrimido[4,5-d]pyrimidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:26979-05-5 SDS

26979-05-5Downstream Products

26979-05-5Relevant academic research and scientific papers

Heterocyclic compound used as MNK inhibitor

-

Paragraph 0167; 0169, (2019/01/08)

The invention relates to a heterocyclic compound, a pharmaceutical composition containing the heterocyclic compound, a preparation method thereof, and application thereof used as a mitogen activated protein kinase interacting kinase 1 and 2-MNK1/MNK2 inhibitor. The inhibitor is the heterocyclic compound as shown in the formula (I), or its pharmaceutically acceptable salt, prodrug, solvent compound, polycrystal, isomer, stable isotope derivative or a pharmaceutical composition containing the heterocyclic compound. The compound of the invention can be used for treating or preventing MNK-mediatedrelated diseases, such as cancers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 26979-05-5